122 related articles for article (PubMed ID: 29687875)
1. Evaluation of thyroid nodule characteristics in subclinical hypothyroid patients under a myo-inositol plus selenium treatment.
Nordio M; Basciani S
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):2153-2159. PubMed ID: 29687875
[TBL] [Abstract][Full Text] [Related]
2. The Role of Inositol in Thyroid Physiology and in Subclinical Hypothyroidism Management.
Benvenga S; Nordio M; Laganà AS; Unfer V
Front Endocrinol (Lausanne); 2021; 12():662582. PubMed ID: 34040582
[TBL] [Abstract][Full Text] [Related]
3. Role of selenium and myo-inositol supplementation on autoimmune thyroiditis progression.
Pace C; Tumino D; Russo M; Le Moli R; Naselli A; Borzì G; Malandrino P; Frasca F
Endocr J; 2020 Nov; 67(11):1093-1098. PubMed ID: 32669509
[TBL] [Abstract][Full Text] [Related]
4. Myo-inositol plus selenium supplementation restores euthyroid state in Hashimoto's patients with subclinical hypothyroidism.
Nordio M; Basciani S
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(2 Suppl):51-59. PubMed ID: 28724185
[TBL] [Abstract][Full Text] [Related]
5. Supplementation with myo-inositol and Selenium improves the clinical conditions and biochemical features of women with or at risk for subclinical hypothyroidism.
Payer J; Jackuliak P; Kužma M; Džupon M; Vaňuga P
Front Endocrinol (Lausanne); 2022; 13():1067029. PubMed ID: 36465640
[TBL] [Abstract][Full Text] [Related]
6. Natural history of mild subclinical hypothyroidism: prognostic value of ultrasound.
Rosário PW; Bessa B; Valadão MM; Purisch S
Thyroid; 2009 Jan; 19(1):9-12. PubMed ID: 19021461
[TBL] [Abstract][Full Text] [Related]
7. Protective Effects of Myo-Inositol and Selenium on Cadmium-Induced Thyroid Toxicity in Mice.
Benvenga S; Marini HR; Micali A; Freni J; Pallio G; Irrera N; Squadrito F; Altavilla D; Antonelli A; Ferrari SM; Fallahi P; Puzzolo D; Minutoli L
Nutrients; 2020 Apr; 12(5):. PubMed ID: 32357526
[TBL] [Abstract][Full Text] [Related]
8. Biochemical follow-up of nonfunctioning benign thyroid nodules.
Memon R; Salgado Nunez Del Prado SR; Lamos EM; Mohtasebi Y; Yip TC; Magder L; Munir KM
Clin Endocrinol (Oxf); 2021 Feb; 94(2):322-329. PubMed ID: 32735709
[TBL] [Abstract][Full Text] [Related]
9. Treatment with Myo-Inositol and Selenium Ensures Euthyroidism in Patients with Autoimmune Thyroiditis.
Nordio M; Basciani S
Int J Endocrinol; 2017; 2017():2549491. PubMed ID: 28293260
[TBL] [Abstract][Full Text] [Related]
10. Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment.
Maraka S; Mwangi R; McCoy RG; Yao X; Sangaralingham LR; Singh Ospina NM; O'Keeffe DT; De Ycaza AE; Rodriguez-Gutierrez R; Coddington CC; Stan MN; Brito JP; Montori VM
BMJ; 2017 Jan; 356():i6865. PubMed ID: 28122781
[TBL] [Abstract][Full Text] [Related]
11. Myo-inositol and selenium reduce the risk of developing overt hypothyroidism in patients with autoimmune thyroiditis.
Ferrari SM; Fallahi P; Di Bari F; Vita R; Benvenga S; Antonelli A
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(2 Suppl):36-42. PubMed ID: 28724175
[TBL] [Abstract][Full Text] [Related]
12. Effects of Zinc and Selenium Supplementation on Thyroid Function in Overweight and Obese Hypothyroid Female Patients: A Randomized Double-Blind Controlled Trial.
Mahmoodianfard S; Vafa M; Golgiri F; Khoshniat M; Gohari M; Solati Z; Djalali M
J Am Coll Nutr; 2015; 34(5):391-9. PubMed ID: 25758370
[TBL] [Abstract][Full Text] [Related]
13. Adequate levothyroxine doses for the treatment of hypothyroidism newly discovered during pregnancy.
Abalovich M; Vázquez A; Alcaraz G; Kitaigrodsky A; Szuman G; Calabrese C; Astarita G; Frydman M; Gutiérrez S
Thyroid; 2013 Nov; 23(11):1479-83. PubMed ID: 23731335
[TBL] [Abstract][Full Text] [Related]
14. The Association of Myo-Inositol and Selenium Contrasts Cadmium-Induced Thyroid C Cell Hyperplasia and Hypertrophy in Mice.
Benvenga S; Micali A; Ieni A; Antonelli A; Fallahi P; Pallio G; Irrera N; Squadrito F; Picciolo G; Puzzolo D; Minutoli L
Front Endocrinol (Lausanne); 2021; 12():608697. PubMed ID: 33716965
[TBL] [Abstract][Full Text] [Related]
15. Effects of controlled ovarian stimulation on thyroid stimulating hormone in infertile women.
Du YJ; Xin X; Cui N; Jiang L; Yang AM; Hao GM; Gao BL
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():207-212. PubMed ID: 30731333
[TBL] [Abstract][Full Text] [Related]
16. Myoinositol in Autoimmune Thyroiditis.
Paparo SR; Ferrari SM; Patrizio A; Elia G; Ragusa F; Botrini C; Balestri E; Guarneri F; Benvenga S; Antonelli A; Fallahi P
Front Endocrinol (Lausanne); 2022; 13():930756. PubMed ID: 35837308
[TBL] [Abstract][Full Text] [Related]
17. Performance of elastography for the evaluation of thyroid nodules: a prospective study.
Azizi G; Keller J; Lewis M; Puett D; Rivenbark K; Malchoff C
Thyroid; 2013 Jun; 23(6):734-40. PubMed ID: 23136893
[TBL] [Abstract][Full Text] [Related]
18. Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study.
Thayakaran R; Adderley NJ; Sainsbury C; Torlinska B; Boelaert K; Šumilo D; Price M; Thomas GN; Toulis KA; Nirantharakumar K
BMJ; 2019 Sep; 366():l4892. PubMed ID: 31481394
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment with Myo-inositol and selenium ensures euthyroidism in subclinical hypothyroidism patients with autoimmune thyroiditis.
Nordio M; Pajalich R
J Thyroid Res; 2013; 2013():424163. PubMed ID: 24224112
[TBL] [Abstract][Full Text] [Related]
20. High-intensity focused ablation (HIFU) of single benign thyroid nodule rarely alters underlying thyroid function.
Lang BHH; Woo YC; Chiu KW
Int J Hyperthermia; 2017 Dec; 33(8):875-881. PubMed ID: 28540804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
